- Home
- TXG vs ASTH Comparison
TXG vs ASTH Comparison
Compare TXG & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- ASTH
- Stock Information
- Founded
- TXG 2012
- ASTH 1994
- Country
- TXG United States
- ASTH United States
- Employees
- TXG N/A
- ASTH N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- ASTH Professional Services
- Sector
- TXG Industrials
- ASTH Consumer Discretionary
- Exchange
- TXG Nasdaq
- ASTH Nasdaq
- Market Cap
- TXG 1.6B
- ASTH 1.5B
- IPO Year
- TXG 2019
- ASTH N/A
- Fundamental
- Price
- TXG $13.32
- ASTH $33.33
- Analyst Decision
- TXG Buy
- ASTH Strong Buy
- Analyst Count
- TXG 12
- ASTH 5
- Target Price
- TXG $13.54
- ASTH $47.40
- AVG Volume (30 Days)
- TXG 2.8M
- ASTH 292.3K
- Earning Date
- TXG 11-06-2025
- ASTH 11-06-2025
- Dividend Yield
- TXG N/A
- ASTH N/A
- EPS Growth
- TXG N/A
- ASTH N/A
- EPS
- TXG N/A
- ASTH 0.52
- Revenue
- TXG $644,466,000.00
- ASTH $2,419,115,000.00
- Revenue This Year
- TXG $2.11
- ASTH $60.87
- Revenue Next Year
- TXG N/A
- ASTH $27.04
- P/E Ratio
- TXG N/A
- ASTH $63.46
- Revenue Growth
- TXG 2.02
- ASTH 51.97
- 52 Week Low
- TXG $6.78
- ASTH $21.20
- 52 Week High
- TXG $18.21
- ASTH $60.99
- Technical
- Relative Strength Index (RSI)
- TXG 57.51
- ASTH 69.10
- Support Level
- TXG $12.08
- ASTH $28.81
- Resistance Level
- TXG $13.45
- ASTH $31.18
- Average True Range (ATR)
- TXG 0.76
- ASTH 1.13
- MACD
- TXG 0.18
- ASTH 0.40
- Stochastic Oscillator
- TXG 95.82
- ASTH 99.62
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.